You are here: Home > Institute of Excellence (CPD) > CPD Events > RLRL: A New Myopia Control Strategy

RLRL: A New Myopia Control Strategy

Provider: Mivision

Contact: Nikki Byrne, [E], [P] 02 8336 8616

Activity Outline

Professor Mingguang He presents the evidence to support the Eyerising, a home-use device originally intended for amblyopia treatment in China, which is successfully being used to slow myopia progression.

Learning Objectives

  • Acquire a comprehensive understanding of the Repeated Low-Level Red-Light (RLRL) Therapy, its underlying principles, and its pivotal role in myopia management, emphasizing its strong efficacy in controlling myopia progression, and the observed phenomenon of axial shortening post-treatment
  • Understand the safety standards and guidelines of RLRL Therapy, drawing insights from ANSI light hazard testing, and gain practical guidance for its clinical adoption
  • Explore the potential future applications of RLRL Therapy, its efficacy when combined with other treatment modalities, and its role in reducing the prevalence of myopia and associated complications in the community

Max CPD hours awarded: 1.25

Session Information

RLRL: A New Myopia Control Strategy
Duration of CPD Session/Module
Duration of CPD Session/Module inclusive of Assessment Component

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.